Explore seven biotech companies advancing clinical drugs in the race for regulatory approval to revolutionize hepatitis B ...

Liver fibrosis is a key process in the progression of chronic liver diseases. However, there are currently no drugs ...

Liver fibrosis is a key process in the progression of chronic liver diseases. However, there are currently no drugs ...

The only lab in the U.S. capable of testing for and tracking antibiotic-resistant gonorrhea, or “super gonorrhea,” was ...

Kurnool: With a spike in hepatitis B and hepatitis C virus cases, the Clinical Microbiology wing at Nandyal Government ...

Premium InsightsThe Hepatitis C drug market is entering a transformative phase as global health organizations, pharmaceutical ...

The U.S. capacity to battle hepatitis B and C has been leveled a devastating blow with the recent closure of the CDC’s ...

Liver diseases are rising globally, claiming over 2 million lives annually, with viral hepatitis and alcoholic liver disease ...

The FDA’s Fast Track designation is intended to speed up the development and review of drugs that treat serious conditions ... clearance to begin the phase I ELIMINATE-B study of PBGENE-HBV for ...

Hepatitis D virus (HDV) infects the liver and causes severe inflammation. According to WHO estimates, 12 million people ...

Uncover what drives alcoholic hepatitis, how it’s detected, and why stopping alcohol is vital for better health and recovery.